Low Libido
Low libido means reduced sexual desire or interest, often noticed as less frequent thoughts about sex or less motivation for sexual activity. It describes the level of desire itself rather than identifying one specific cause.
A clear starting point for understanding Low Libido and its place within hormonal health.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
1 option:1 not enough evidence
Red Light Therapy (Photobiomodulation)practiceNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A secondary analysis of a randomized trial reported improvement in the SAFTEE sex total score compared with sham.
Open the Red Light Therapy (Photobiomodulation) page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition1 listedThe best we have, but the evidence is still weak
- →PracticesRed Light Therapy (Photobiomodulation)CertaintyLowSourceClinical
A secondary analysis of a randomized trial reported improvement in the SAFTEE sex total score compared with sham.
Who was studied
- People with a condition
- Alzheimers Disease
- Anxiety Disorder
- Depression
- Low Libido
- Parkinsons Disease
- Schizophrenia
- +1 more
Open Red Light Therapy (Photobiomodulation)Study result
Secondary analysis of RCT showed significant improvement in SAFTEE sex total score vs sham.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Low Libido worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Low libido means reduced sexual desire or interest, often noticed as less frequent thoughts about sex or less motivation for sexual activity. It describes the level of desire itself rather than identifying one specific cause. Low libido is considered here within hormonal health, and may be discussed in relation to sexual well-being and, in some research, testosterone.
Evidence-backed options
The options associated with Low Libido are supported by different types of evidence. Ashwagandha has clinical evidence, while Tribulus Terrestris, Horny Goat Weed (Epimedium), and Maca Root are presented through pharmacology references. This means the strength and nature of support are not uniform across the options, and traditional or reference-based use should not be interpreted as equivalent to findings from clinical research.
The available findings address several broad themes, including subjective sexual well-being, sexual desire, testosterone modulation, and blood-flow effects. These themes do not establish that every option works for every person, and the evidence does not identify a single shared mechanism or response pattern across them.
The health status of the people studied is not specified. That limits how confidently the findings can be applied to particular causes of Low Libido or to specific groups. Details about what was taken, the duration of use, and how quickly effects appeared are not provided here, so timing and treatment-course comparisons cannot be made. The evidence should therefore be read as preliminary or context-dependent rather than as a definitive treatment recommendation. Anyone evaluating persistent or bothersome changes in sexual desire should discuss possible causes and options with a clinician.